Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.2M Buy
553,555
+176,000
+47% +$19.4M 1.14% 25
2026
Q1
$39.7M Sell
377,555
-97,400
-21% -$11.4M 1.18% 21
2025
Q4
$59.3M Buy
474,955
+81,135
+21% +$9.67M 1.32% 28
2025
Q3
$47.2M Buy
+393,820
New +$41.6M 1.16% 28
2024
Q4
Sell
-162,500
Closed -$15.1M 87
2024
Q3
$15.1M Buy
+162,500
New +$13.6M 0.51% 37

Other funds holding CRH

Duquesne Family Office's CRH Position: Q2 2026 in Review

Duquesne Family Office increased its CRH (CRH) stake by 47% in Q2 2026, buying an estimated $19.4M and bringing the position to 553,555 shares worth $59.2M. The position accounts for 1.14% of the portfolio, ranked #25.

Duquesne Family Office first reported a position in CRH in Q3 2024 and has held it in 5 quarters since. The position peaked at $59.3M in Q4 2025. 1,029 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Duquesne Family Office held 553,555 shares of CRH worth $59.2M as of Q2 2026.
  • Duquesne Family Office bought 176,000 CRH shares in Q2 2026, an estimated $19.4M.
  • CRH made up 1.14% of Duquesne Family Office's portfolio in Q2 2026, its #25 holding.
  • Duquesne Family Office first reported a position in CRH in Q3 2024 and has held it in 5 quarters since.
  • Duquesne Family Office's CRH position peaked at $59.3M in Q4 2025.
  • 1,029 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Duquesne Family Office's 13F filing for Q2 2026, filed 14 Aug 2026.